Previous 10 | Next 10 |
BOSTON and GENEVA, Switzerland, Sept. 20, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will host its first-ever Investor Day TODAY in-person at PUBLIC Hotel in New York City. The event will begin at 1:30 p.m. EDT and is ex...
The following slide deck was published by SOPHiA GENETICS SA in conjunction with their 2022 Q2 earnings call. For further details see: SOPHiA GENETICS SA 2022 Q2 - Results - Earnings Call Presentation
Summary Generation Investment Management’s 13F portfolio value decreased from $21.84B to $18.35B this quarter. They added Mastercard and increased Amazon.com, Microsoft, Trane Technologies, and Analog Devices while reducing Baxter International, Becton Dickinson, and Alphab...
BOSTON and LAUSANNE, Switzerland, Sept. 02, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today Chief Executive Officer, Dr. Jurgi Camblong and Chief Financial Officer, Ross Muken will participate in a fireside...
SOPHiA GENETICS SA (SOPH) Q2 2022 Results Conference Call August 09, 2022 08:30 AM ET Company Participants Jennifer Pottage - Head, IR Dr. Jurgi Camblong - Co-Founder and CEO Ross Muken - CFO Conference Call Participants Julia Qin - JP Morgan Vidy...
Image source: The Motley Fool. Sophia Genetics SA (NASDAQ: SOPH) Q2 2022 Earnings Call Aug 09, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Sophia Genetics SA (SOPH) Q2 2022 Earnings Call Transcript
SOPHiA Genetics press release ( NASDAQ: SOPH ): Q2 GAAP EPS of -$0.39 in-line. Revenue of $11.7M (+15.0% Y/Y) misses by $0.25M . For further details see: SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M
BOSTON and LAUSANNE, Switzerland, Aug. 09, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the second quarter ended June 30, 2022. Recent Highlights Revenue for the seco...
BOSTON and LAUSANNE, Switzerland, Aug. 04, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, announced today it will host its first-ever Investor Day on Tuesday, September 20, 2022, at PUBLIC Hotel in New York City. The even...
BOSTON and LAUSANNE, Switzerland, July 29, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, announced today Chief Financial Officer, Ross Muken, will attend and be a panelist at the Canaccord Genuity 42 nd Annual Growth Conference on Thursday...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ Canada NewsWire The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 2...
SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24 , 2024 /PRN...
SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix PR Newswire OncoHelix is the first laboratory in Canada to adopt MSK-ACCESS ® powered with SOPHiA DDM™ BOSTON and ROLLE, Switzerland , July 24, 2024 /...